ValuEngine upgraded shares of GeoVax Labs Inc. (OTCMKTS:GOVX) from a strong sell rating to a sell rating in a research note issued to investors on Friday.

Shares of GeoVax Labs (GOVX) opened at $0.08 on Friday. GeoVax Labs has a 1 year low of $0.02 and a 1 year high of $0.08.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at

GeoVax Labs Company Profile

GeoVax Labs, Inc (GeoVax) is a clinical-stage biotechnology company. The Company is engaged in developing human vaccines against infectious diseases using its modified vaccine Ankara-virus-like particles (MVA-VLP) vaccine platform. The Company’s platform supports in vivo expression of non-infectious virus-like particles (VLPs) from the cells of the person receiving the vaccine.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for GeoVax Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.